The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of arsenic trioxide combined with cART in eliminating
latent HIV-1 reservoir, providing potential strategies for AIDS functional cure.
Phase:
Phase 1
Details
Lead Sponsor:
Guangzhou 8th People's Hospital
Collaborator:
Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences